bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Окт. 12, 2023
ABSTRACT
Coronaviruses
have
caused
three
severe
epidemics
since
the
start
of
21
st
century:
SARS,
MERS
and
COVID-19.
The
severity
ongoing
COVID-19
pandemic
increasing
likelihood
future
coronavirus
outbreaks
motivates
greater
understanding
factors
leading
to
disease.
We
screened
ten
strains
from
Collaborative
Cross
mouse
genetic
reference
panel
identified
CC006/TauUnc
(CC006)
CC044/Unc
(CC044)
as
coronavirus-susceptible
resistant,
respectively,
indicated
by
variable
weight
loss
lung
congestion
scores
four
days
post-infection.
generated
a
mapping
population
755
CC006xCC044
F2
mice
exposed
one
genetically
distinct
mouse-adapted
coronaviruses:
clade
1a
SARS-CoV
MA15
(n=391),
1b
SARS-CoV-2
MA10
(n=274),
2
HKU3-CoV
MA
(n=90).
Quantitative
trait
loci
(QTL)
in
SARS-CoV-
SARS-CoV-2-infected
associated
with
disease
severity.
Specifically,
we
seven
variation
outcome
following
infection
either
virus,
including
one,
HrS45
,
that
is
present
both
groups.
Three
these
QTL,
were
also
outcome.
overlaps
QTL
previously
reported
our
lab
CC011xCC074
syntenic
human
chromosomal
region
outcomes
humans
GWAS.
results
here
provide:
(a)
additional
support
for
involvement
this
locus
infection,
(b)
first
conclusive
evidence
susceptibility
across
Sarbecovirus
subgenus,
(c)
demonstration
relevance
models
study
humans.
Cell Reports,
Год журнала:
2023,
Номер
42(4), С. 112326 - 112326
Опубликована: Март 30, 2023
Group
2B
β-coronaviruses
(sarbecoviruses)
have
caused
regional
and
global
epidemics
in
modern
history.
Here,
we
evaluate
the
mechanisms
of
cross-sarbecovirus
protective
immunity,
currently
less
clear
yet
important
for
pan-sarbecovirus
vaccine
development,
using
a
panel
alphavirus-vectored
vaccines
covering
bat
to
human
strains.
While
vaccination
does
not
prevent
virus
replication,
it
protects
against
lethal
heterologous
disease
outcomes
both
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
clade
sarbecovirus
challenge
models.
The
spike
tested
primarily
elicit
highly
S1-specific
homologous
neutralizing
antibody
response
with
no
detectable
cross-virus
neutralization.
Rather,
non-neutralizing
functions,
mechanistically
linked
FcgR4
S2,
mediate
cross-protection
wild-type
mice.
Protection
is
lost
FcR
knockout
mice,
further
supporting
model
non-neutralizing,
antibodies.
These
data
highlight
importance
FcR-mediated
cross-protective
immune
responses
universal
designs.
Clinical and Translational Allergy,
Год журнала:
2024,
Номер
14(5)
Опубликована: Апрель 30, 2024
Abstract
Background
Gut
microbiota
are
closely
related
to
the
development
and
regulation
of
host
immune
system
by
regulating
maturation
cells
resistance
pathogens,
which
affects
immunity.
Early
use
antibiotics
disrupts
homeostasis
gut
increases
risk
asthma.
actively
interact
with
via
gut‐lung
axis,
a
bidirectional
communication
pathway
between
lung.
The
manipulation
through
probiotics,
helminth
therapy,
fecal
transplantation
(FMT)
combat
asthma
has
become
hot
research
topic.
Body
This
review
mainly
describes
current
pathogenesis
asthma,
role
axis
in
Moreover,
potential
manipulating
its
metabolites
as
treatment
strategy
for
been
discussed.
Conclusion
effect
on
microecology
imbalance
contributes
bacterial
structural
components
metabolites.
Asthma,
turn,
can
also
cause
intestinal
damage
inflammation
throughout
body.
FMT
inform
strategies
pathogens.
Cell Reports,
Год журнала:
2024,
Номер
43(5), С. 114127 - 114127
Опубликована: Апрель 21, 2024
Ebola
virus
(EBOV),
a
major
global
health
concern,
causes
severe,
often
fatal
EBOV
disease
(EVD)
in
humans.
Host
genetic
variation
plays
critical
role,
yet
the
identity
of
host
susceptibility
loci
mammals
remains
unknown.
Using
reference
populations,
we
generate
an
F2
mapping
cohort
to
identify
that
regulate
EVD.
While
disease-resistant
mice
display
minimal
pathogenesis,
susceptible
severe
liver
pathology
consistent
with
EVD-like
and
transcriptional
signatures
associated
inflammatory
metabolic
processes.
A
significant
quantitative
trait
locus
(QTL)
for
RNA
load
blood
is
identified
chromosome
(chr)8,
clinical
mortality
QTL
mapped
chr7,
which
includes
Trim5
locus.
knockout
mice,
validate
as
one
potential
driver
failure
after
infection.
The
identification
provides
insight
into
molecular
mechanisms
regulating
EVD
progression
severity,
potentially
informing
therapeutics
vaccination
strategies.
Virus Research,
Год журнала:
2024,
Номер
344, С. 199357 - 199357
Опубликована: Март 23, 2024
Coronavirus
(CoV)
cause
considerable
morbidity
and
mortality
in
humans
other
mammals,
as
evidenced
by
the
emergence
of
Severe
Acute
Respiratory
CoV
(SARS-CoV)
2003,
Middle
East
(MERS-CoV)
2012,
SARS-CoV-2
2019.
Although
poorly
characterized,
natural
genetic
variation
human
mammals
modulate
virus
pathogenesis,
reflected
spectrum
clinical
outcomes
ranging
from
asymptomatic
infections
to
lethal
disease.
Using
multiple
epidemic
zoonotic
Sarbecoviruses,
coupled
with
murine
Collaborative
Cross
reference
populations,
we
identify
several
dozen
quantitative
trait
loci
that
regulate
SARS-like
group-2B
pathogenesis
replication.
Under
a
Chr4
QTL,
deleted
candidate
interferon
stimulated
gene,
Trim14
which
resulted
enhanced
SARS-CoV
titers
disease,
suggesting
an
antiviral
role
during
infection.
Importantly,
about
60
%
QTL
encode
susceptibility
genes
identified
priority
candidates
genome-wide
association
studies
(GWAS)
after
infection,
similar
selective
forces
have
targeted
analogous
pathways
Sarbecovirus
disease
across
diverse
mammalian
hosts.
These
provide
experimental
platform
rodents
investigate
molecular-genetic
mechanisms
potential
cross
type-specific
cross-SARS-like
group
2B
replication,
immunity,
rodent
models.
Our
study
also
provides
paradigm
for
identifying
highly
heterogeneous
virulent
viruses
sporadically
emerge
reservoirs
plague
animal
populations.
Science Translational Medicine,
Год журнала:
2024,
Номер
16(773)
Опубликована: Ноя. 13, 2024
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV
2)
pandemic
has
caused
more
than
7
million
deaths
globally.
Despite
the
presence
of
infection-
and
vaccine-induced
immunity,
SARS-CoV-2
infections
remain
a
major
global
health
concern
because
emergence
variants
that
can
cause
disease
2019
(COVID-19)
or
enhance
Long
Covid
phenotypes.
About
5
to
10%
SARS-CoV-2-infected
individuals
develop
Covid,
which,
similar
COVID
19,
often
affects
lung.
However,
also
affect
other
peripheral
organs,
especially
brain.
causal
relationships
between
phenotypes,
long-term
symptoms,
involvement
multiple
organ
systems
elusive,
animal
model
mimicking
both
post-acute
phases
are
imperative.
Here,
we
review
current
state
models,
including
possible
future
applications.
Hepatology,
Год журнала:
2023,
Номер
79(1), С. 183 - 197
Опубликована: Авг. 4, 2023
Background
&
Aims:
Human
genetic
variation
is
thought
to
guide
the
outcome
of
HCV
infection,
but
model
systems
within
which
dissect
these
host
mechanisms
are
limited.
Norway
rat
hepacivirus,
closely
related
HCV,
causes
chronic
liver
infection
in
rats
acute
self-limiting
hepatitis
typical
strains
laboratory
mice,
resolves
2
weeks.
The
Collaborative
Cross
(CC)
a
robust
mouse
genetics
resource
comprised
panel
recombinant
inbred
strains,
complexity
human
genome
and
provide
system
understand
diseases
driven
by
complex
allelic
variation.
Approach
Results:
We
infected
CC
with
hepacivirus
identified
several
that
failed
clear
virus
after
4
Strains
displayed
an
array
virologic
phenotypes
ranging
from
delayed
clearance
(CC046)
chronicity
(CC071,
CC080)
viremia
for
at
least
10
months.
Body
weight
loss,
hepatocyte
frequency,
viral
evolution,
T-cell
recruitment
liver,
inflammation,
capacity
develop
fibrosis
varied
among
strains.
Conclusions:
These
models
recapitulate
many
aspects
humans
demonstrate
affects
multitude
viruses
phenotypes.
can
be
used
better
molecular
drive
chronicity,
interactions
promote
disease
manifestations
like
fibrosis,
therapeutic
vaccine
performance,
how
factors
affected
Vaccines,
Год журнала:
2024,
Номер
12(1), С. 103 - 103
Опубликована: Янв. 20, 2024
The
COVID-19
pandemic
led
to
the
rapid
and
worldwide
development
of
highly
effective
vaccines
against
SARS-CoV-2.
However,
there
is
significant
individual-to-individual
variation
in
vaccine
efficacy
due
factors
including
viral
variants,
host
age,
immune
status,
environmental
genetic
factors.
Understanding
those
determinants
driving
this
may
inform
more
broadly
protective
strategies.
While
are
known
impact
for
respiratory
pathogens
such
as
influenza
tuberculosis,
on
not
well
understood.
To
model
SARS-CoV-2
efficacy,
while
controlling
non-genetic
factors,
we
used
Diversity
Outbred
(DO)
mouse
model.
We
found
that
DO
mice
immunized
exhibited
high
levels
vaccine-induced
neutralizing
antibody
responses.
majority
vaccinated
were
protected
from
virus-induced
disease,
similar
human
populations,
observed
breakthrough
a
subset
mice.
Importantly,
antibody,
titer
heritable,
indicating
serves
useful
system
studying
contribution
both
disease
outcomes.
Abstract
The
Crimean-Congo
hemorrhagic
fever
virus
(CCHFV)
causes
(CCHF),
a
widely
distributed
disease
with
significant
morbidity
and
mortality.
has
high
genetic
diversity
correlated
geographic
distribution
but
limited
temporal
evolution
within
regions.
Despite
this,
cases
of
CCHF
region
present
as
spectrum
from
often
unrecognized
asymptomatic
infections
to
severe,
fatal
viral
fever,
suggesting
host
factors
may
play
role
in
outcome.
We
investigated
the
effect
on
outcome
CCHFV
infection
genetically
diverse
Collaborative
cross
(CC)-mouse
model.
Infected
mice
recapitulated
full
recognized
humans,
similar
human
disease,
replication,
tissue
pathology,
inflammatory
responses
were
associated
severity.
Our
study
demonstrates
that
genetics
contribute
establishes
CC
mouse
resource
model
understand
how
contributes
iScience,
Год журнала:
2024,
Номер
27(3), С. 109103 - 109103
Опубликована: Фев. 2, 2024
The
response
to
infection
is
generally
heterogeneous
and
diverse,
with
some
individuals
remaining
asymptomatic
while
others
present
severe
disease
or
a
diverse
range
of
symptoms.
Here,
we
address
the
role
host
genetics
on
immune
phenotypes
clinical
outcomes
following
viral
by
studying
genetically
mice
from
Collaborative
Cross
(CC),
allowing
for
use
small
animal
model
controlled
genetic
diversity
maintaining
replicates.
We
demonstrate
variation
deeply
profiling
broad
innate
adaptive
cell
at
steady-state
in
63
distinct
CC
mouse
strains
link
baseline
signatures
virologic
herpes
simplex
virus
2
(HSV-2)
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2).
This
work
serves
as
resource
strain
selection
based
presentation
upon
infection,
further,
points
possible
pre-infection
correlates
survival
early
clearance
infection.